Cost Management Insights: SG&A Expenses for Bio-Techne Corporation and Walgreens Boots Alliance, Inc.

SG&A Expenses: Bio-Techne vs. Walgreens Boots Alliance

__timestampBio-Techne CorporationWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20146071600017992000000
Thursday, January 1, 201511940100022400000000
Friday, January 1, 201614087900023910000000
Sunday, January 1, 201719924300023813000000
Monday, January 1, 201824063600024694000000
Tuesday, January 1, 201926435900023557000000
Wednesday, January 1, 202026058300025436000000
Friday, January 1, 202132495100024586000000
Saturday, January 1, 202237276600027295000000
Sunday, January 1, 202337837800034205000000
Monday, January 1, 202439682600028113000000
Loading chart...

Unleashing the power of data

Navigating SG&A Expenses: A Tale of Two Giants

In the ever-evolving landscape of corporate finance, understanding cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry titans: Bio-Techne Corporation and Walgreens Boots Alliance, Inc., from 2014 to 2024. Over this decade, Bio-Techne's SG&A expenses surged by over 550%, reflecting its strategic investments in growth and innovation. In contrast, Walgreens Boots Alliance maintained a steady trajectory, with expenses increasing by approximately 60%, underscoring its focus on operational efficiency.

Key Insights

  • Bio-Techne Corporation: From a modest start in 2014, SG&A expenses grew significantly, peaking in 2024. This growth highlights the company's aggressive expansion and market penetration strategies.
  • Walgreens Boots Alliance, Inc.: Despite fluctuations, the company consistently managed its expenses, showcasing resilience and adaptability in a competitive retail environment.

This comparative analysis offers valuable insights into how these corporations navigate financial challenges and opportunities.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025